Join Us For A Webinar on June 9, 2020
Webinar presented by Mednet and MedTrials, Inc.
The Pandemic Push: Driving Disruption and Lasting Transformation in Clinical Trial ManagementTuesday, June 9 at 1:00 p.m. ET Objective: As a result of attending this webinar, attendees will be able to describe how industry leaders are redefining traditional trial management practices with lessons learned from the impact of COVID-19. Purpose: The COVID-19 pandemic served as a wake-up call to the clinical trial industry which otherwise has been historically slow to change. For years, many have discussed the need for disruption, but traditional ways prevailed despite the introduction of new technologies and regulatory guidance that nods to the acceptance of innovation and risk-adapted approaches. With an abrupt halt, most organizations had to quickly react and pivot to ensure the protection of subjects and integrity of data remotely in ongoing trials. After months of unplanned disruption, there have been many lessons learned and an awakening with an apparent openness to change and a real potential to shorten development timelines. Could it be that our industry is ready to not just do the same things differently, but to do different things? Going “remote” is not enough. We must now consider how sponsors and CROs can use this pandemic push to drive meaningful transformation. Now is the time to drive disruptive innovation by using technology and teams to approach clinical trial management from a different angle with the goal of achieving higher quality and improved efficiency. This webinar is a must-attend for managers and business leaders responsible for innovation and growth at sponsor and CRO organizations. Learn how MedTrials and Mednet have worked together to adapt to challenges posed by the COVID-19 pandemic and how Sponsors and CROs can use lessons learned to drive meaningful change for clinical trial management.
Topics to be discussed, include:
- Opportunities for proactive planning and collaboration for more effective study management
- The need to challenge long standing assumptions and best practices
- Optimizing use of electronic tools
- How to realign roles and responsibilities to maximize efficiency
Meet Our Panelists
President and CEO, Mednet
Rob is the president and CEO of Mednet, responsible for the overall strategic direction of the organization. As a cofounder, Rob led Mednet’s rapid growth into a leading global provider of eClinical solutions. Prior to Mednet, Rob held multiple leadership roles in a variety of companies in the healthcare industry.
Lynn D. Van Dermark, RN, MBA, CCRA, RAC, FACRP
Lynn is founding partner and CEO of MedTrials with a BS in Nursing from the University of Virginia and an MBA from Baylor University. Lynn is a clinical trial management consultant, GCP and quality systems expert who maintains certifications in clinical research and regulatory affairs. She is an adjunct professor for clinical research studies at the UNT Graduate School of Biomedical Sciences and is active with Association of Clinical Research Professionals (ACRP) as a Fellow and past Chair of the Association Board of Trustees.
Bridget Browder, MS, CCRC
Manager, Learning and Development, MedTrials
Bridget leads MedTrials training services and is an eLearning innovator and strategic advisor for driving change and working differently. Bridget holds a Masters in Clinical Research Management and she is a dynamic industry trainer, an adjunct professor for clinical research studies at the UNT Graduate School of Biomedical Sciences, and is actively involved in the Association of Clinical Research Professionals (ACRP) as a current member of the Content Advisory Board for the global ACRP Annual Meeting.
Jody has been serving Mednet customers for almost 9 years, supporting a wide range of studies including medical device (musculoskeletal/orthopedic, ophthalmology, cardiac and others), pharmaceutical and biotech. Her deep technical experience gives her a unique perspective on building studies within iMednet and creating a positive end-user experience.